Is Inspire Medical Systems Inc (INSP) overvalued? · P/E 9.4, rev $802.8M
Inspire Medical Systems Inc (INSP) is a medical devices company listed on US.
This page asks whether Inspire Medical Systems Inc (INSP) looks expensive on cached numbers — not a short thesis.
Latest reported INSP revenue for 2024-12-31 was $802.8M. Net income was $53.5M. Revenue was up 28.5% from 2023-12-31 to 2024-12-31. INSP currently screens at market cap $1.19B and trailing P/E 9.4.
INSP currently screens at market cap $1.19B and trailing P/E 9.4. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next INSP 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the INSP stock page for the full model, not this heading.
Not investment advice.